Skip to main content

Edible Mushrooms as Neuro-nutraceuticals: Basis of Therapeutics

  • Chapter
  • First Online:

Abstract

Mushrooms, the macro-fungi with distinctive fruiting bodies and mycelia, are valued throughout the world not only for their nutritive values but also for their medicinal uses. The former desirable property of mushrooms derives out of their rich contents of vitamins, trace elements, and minerals and appetite-enhancing flavors, but the therapeutic values result from its antioxidant and immunomodulatory activities, from its ability to activate very specific neuronal receptors, and from its capacity to rejuvenate cellular metabolism. Reactive oxygen species cause extensive damage to cells and tissues by interfering with normal metabolism, which are aggravated during stressful environments, such as during infections, stress, metabolic diseases, and various degenerative disorders including neurodegenerative diseases, cardiovascular diseases, and accelerated or normal aging. Mushrooms contain many biologically dynamic compounds, some of which are neuroactive substances, free radical scavengers, anti-apoptotic factors, and nerve growth factor stimulators that exert positive effects on brain cells, all of which essentially qualify them as good neuro-nutraceuticals that help in the protection of different neural cells, in vivo and in vitro. While discussing the neuroprotective and neuromodulatory properties of mushrooms, we rationally postulate here indirect benefits of these fungi through the enhanced environment for gut microbiome that are meaningful for healthy brain functions.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

ROS:

Reactive oxygen species

LPS:

Lipopolysaccharides

RNS:

Reactive nitrogen species

ER:

Endoplasmic reticulum

TNF:

Tumor necrosis factor

CNS:

Central nervous system

NGF:

Nerve growth factor

BBB:

Blood-brain barrier

AD:

Alzheimer’s disease

ICV:

Intracerebroventricular

STZ:

Streptozotocin

PKC:

Protein kinase C

PD:

Parkinson’s disease

MPP+ :

1-Methyl-4-phenylpyridinium

MPTP:

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

GDNF:

Glial cell-derived neurotrophic factor

BDNF:

Brain-derived neurotrophic factor

OCTN1:

Organic cation transporter

SLC22A4:

Solute carrier family 22, member 4

IL-1β:

Interleukin 1β

JNK:

c-Jun N-terminal kinases

p38 MAPK:

p38 mitogen-activated protein kinases

IRE1α:

Inositol-requiring protein 1alpha

TRAF2:

TNF receptor-associated factor 2

C/EBP:

CCAAT-enhancer-binding proteins

CHOP :

C/EBP homologous protein

NF-κB:

Nuclear factor-κB

Bax:

Bcl-2-associated protein x

Bcl-2:

B-cell lymphoma 2

PKB/Akt:

Protein kinase B

mTOR:

The mammalian target of rapamycin

Bid:

BH3 interacting-domain death agonist

References

Download references

Acknowledgments

We acknowledge the financial support from Department of Health and Family Welfare and Department of Higher Education, Government of Kerala, India. Mahatma Gandhi University acts as our mentoring institution, support of which is acknowledged.

Conflict of Interests

The authors declare no conflict of interest in publishing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. P. Mohanakumar .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Remya, V.R., Chandra, G., Mohanakumar, K.P. (2019). Edible Mushrooms as Neuro-nutraceuticals: Basis of Therapeutics. In: Agrawal, D., Dhanasekaran, M. (eds) Medicinal Mushrooms. Springer, Singapore. https://doi.org/10.1007/978-981-13-6382-5_2

Download citation

Publish with us

Policies and ethics